These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16952068)

  • 1. Antimicrobial Resistance--2006 Annual Conference. Science--prevention--control. 26-28 June 2006, Bethesda, MD, USA.
    Theuretzbacher U
    IDrugs; 2006 Sep; 9(9):622-4. PubMed ID: 16952068
    [No Abstract]   [Full Text] [Related]  

  • 2. Interscience Conference on Antimicrobial Agents and Chemotherapy--46th annual meeting. 27-30 September 2006, San Francisco, CA, USA.
    Turner B
    IDrugs; 2006 Nov; 9(11):761-4. PubMed ID: 17096294
    [No Abstract]   [Full Text] [Related]  

  • 3. [The ICAAC 1998 (Interscience Conference on Antimicrobial Agents and Chemotherapy). San Diego, California, USA. September 24-27 , 1998. Proceedings].
    Presse Med; 1998 Dec; 27 Suppl 5():5-54. PubMed ID: 9879326
    [No Abstract]   [Full Text] [Related]  

  • 4. Assaying potency of novel vaccines. October 11-12, 2005, Bethesda, MD, USA.
    Sheets R
    Expert Rev Vaccines; 2006 Jun; 5(3):315-8. PubMed ID: 16827616
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges in pharmacodynamic studies of antimicrobial resistance.
    Rapp RP; Campion JJ
    Ann Pharmacother; 2003 Sep; 37(9):1329-30. PubMed ID: 12921518
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of enrofloxacin in chicken.
    Kan CA
    Br Poult Sci; 1997 Dec; 38(5):614. PubMed ID: 9511011
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic options in an era of decreasing antimicrobial susceptibility.
    Drlica K; Schmitz FJ
    J Chemother; 2002 Feb; 14 Suppl 2():5-12. PubMed ID: 12003139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interscience Conference on Antimicrobial Agents and Chemotherapy--48th Annual Meeting and Infectious Diseases Society of America-- 46th Annual Meeting Updates on therapeutic research--Part 2.
    Sovran L
    IDrugs; 2009 Jan; 12(1):3-4. PubMed ID: 19127493
    [No Abstract]   [Full Text] [Related]  

  • 9. Interscience Conference on Antimicrobial Agents and Chemotherapy--48th Annual Meeting and Infectious Diseases Society of America-- 46th Annual Meeting Updates on therapeutic research--Part 1.
    Gale S
    IDrugs; 2009 Jan; 12(1):1-2. PubMed ID: 19127492
    [No Abstract]   [Full Text] [Related]  

  • 10. Limitations of MIC as the sole criterion in antimicrobial drug dosage regimen design: the need for full characterization of antimicrobial pharmacodynamic profile especially for drug-resistant organisms.
    Gehring R; Riviere JE
    Vet J; 2013 Oct; 198(1):15-8. PubMed ID: 24025153
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.
    Hoffman-Roberts HL; Obritsch MD; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Apr; 100(4):105-11. PubMed ID: 17476993
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased momentum in antimicrobial resistance research.
    Matthiessen L; Bergström R; Dustdar S; Meulien P; Draghia-Akli R
    Lancet; 2016 Aug; 388(10047):865. PubMed ID: 27597459
    [No Abstract]   [Full Text] [Related]  

  • 13. . . . from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy.
    Res Initiat Treat Action; 2000 Dec; 6(4):28-31. PubMed ID: 11708173
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance.
    Nuti R; Goud NS; Saraswati AP; Alvala R; Alvala M
    Curr Med Chem; 2017; 24(38):4303-4314. PubMed ID: 28814242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research councils unite to tackle antimicrobial resistance.
    Vet Rec; 2014 Jul; 175(4):79. PubMed ID: 25059955
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoroquinolone AUIC break points and the link to bacterial killing rates: in vitro models.
    Zhanel GG; Noreddin AM
    Ann Pharmacother; 2003 Sep; 37(9):1331-4. PubMed ID: 12921519
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial resistance: in terms politicians understand.
    Lancet; 2014 Dec; 384(9961):2173. PubMed ID: 25625379
    [No Abstract]   [Full Text] [Related]  

  • 18. The future control of bacterial resistance to antimicrobial agents.
    Andremont A
    Am J Infect Control; 2001 Aug; 29(4):256-8. PubMed ID: 11486268
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial resistance at the interface of human and veterinary medicine.
    Köck R; Kreienbrock L; van Duijkeren E; Schwarz S
    Vet Microbiol; 2017 Feb; 200():1-5. PubMed ID: 27916320
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit.
    Lodise TP; Drusano GL
    Crit Care Clin; 2011 Jan; 27(1):1-18. PubMed ID: 21144983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.